SLN Competitors & Alternatives

Compare Silence Therapeutics PLC with similar stocks in the same industry

Biotechnology

SLN

Main Stock
$9.29
Tradestie Score
58
Market Cap
$240.89M
Revenue Growth
2.0%
Analyst Upside
+214.0%

Top Competitors

233 stocks in Biotechnology
Company Price Market Cap P/E Score Action
ABSI Absci Corporation Common Stock
$10.21
$468.01M - 54 Compare
GLUE Monte Rosa Therapeutics, Inc. Common Stock
$21.98
$463.20M - 59 Compare
SLDB Solid Biosciences Inc. Common Stock
$9.72
$457.09M - 60 Compare
MRVI Maravai LifeSciences Holdings, Inc. Class A Common Stock
$6.36
$454.29M - 58 Compare
RAPT RAPT Therapeutics, Inc. Common Stock
$58.02
$450.49M - 53 Compare
MLTX MoonLake Immunotherapeutics Class A Ordinary Shares
$20.41
$448.32M - 60 Compare
ATXS Astria Therapeutics, Inc. Common Stock
$12.58
$425.52M - 58 Compare
ALMS Alumis Inc. Common Stock
$28.10
$422.50M - 61 Compare
DRUG Bright Minds Biosciences Inc. Common Stock
$75.93
$410.79M - 57 Compare
FDMT 4D Molecular Therapeutics, Inc. Common Stock
$11.30
$407.71M - 56 Compare

Data updated: Jul 14, 2026 | Industry: Biotechnology (SIC 2834)

233 stocks in this industry